Rchr
J-GLOBAL ID:200901070708003456   Update date: Feb. 17, 2024

Matsushita Hiromichi

マツシタ ヒロミチ | Matsushita Hiromichi
Affiliation and department:
Job title: Professor
Research field  (2): Other ,  Hematology and oncology
Research keywords  (2): Laboratory Medicine ,  Leukemia
Research theme for competitive and other funds  (8):
  • 2019 - 2022 Establishment of detection systems for minimum residual diseases of mature lymphoid malignancies using flow cytometry
  • 2016 - 2019 Significance of evaluating RUNX3 expression in acute myeloid leukemia
  • 2012 - 2015 In vivo analysis of gene mutations related to epigenetic alterations in acute myeloid leukemia
  • 2009 - 2011 Genetic abnormality require their specific differentiation stage in leukemogenensis
  • 2007 - 2008 Differentiation induction of the myelomonocytic cells with C/EBPs and PU.1
Show all
Papers (109):
  • Hiroki Inoue, Taku Kanda, Gakuto Hayashi, Ryota Munenaga, Masayuki Yoshida, Kana Hasegawa, Takuya Miyagawa, Yukiya Kurumada, Jumpei Hasegawa, Tomoyuki Wada, et al. A MAP1B-cortactin-Tks5 axis regulates TNBC invasion and tumorigenesis. The Journal of cell biology. 2024. 223. 3
  • Yoshifumi Uwamino, Kengo Nagashima, Ayumi Yoshifuji, Shigeru Suga, Mizuho Nagao, Takao Fujisawa, Munekazu Ryuzaki, Yoshiaki Takemoto, Ho Namkoong, Masatoshi Wakui, et al. Estimating immunity with mathematical models for SARS-CoV-2 after COVID-19 vaccination. npj Vaccines. 2023. 8. 1
  • Masayuki Komatsu, Hitoshi Ichikawa, Fumiko Chiwaki, Hiromi Sakamoto, Rie Komatsuzaki, Makoto Asaumi, Kazuhisa Tsunoyama, Takeo Fukagawa, Hiromichi Matsushita, Narikazu Boku, et al. ARHGAP-RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer. Oncogene. 2022
  • Suguru Fukuhara, Yuji Oshikawa-Kumade, Yasunori Kogure, Sumito Shingaki, Hirokazu Kariyazono, Yoshiya Kikukawa, Junji Koya, Yuki Saito, Mariko Tabata, Kota Yoshifuji, et al. Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies. Cancer science. 2022. 113. 8. 2763-2777
  • Naoki Kojima, Yasuhito Arai, Kaishi Satomi, Takashi Kubo, Yuko Matsushita, Taisuke Mori, Hiromichi Matsushita, Toshikazu Ushijima, Yasushi Yatabe, Tatsuhiro Shibata, et al. Co-expression of ERG and CD31 in a subset of CIC-rearranged sarcoma: a potential diagnostic pitfall. MODERN PATHOLOGY. 2022
more...
MISC (61):
  • 片平 泰弘, 樋口 廣士, 山本 雄一郎, 安藤 潔, 幸谷 愛, 松下 弘道, 八幡 崇, 小池 亮, 佐藤 克明, 今留 謙一, et al. Increased Granulopoiesis in the Bone Marrow following Epstein-Barr Virus Infection(和訳中). 東京医科大学雑誌. 2020. 78. 3. 290-291
  • Hidetsugu Kawai, Hiromichi Matsushita, Yasuyuki Aoyama, Keiko Matsui, Makoto Onizuka, Kiyoshi Ando. Dysplastic features seen in a patient with acute myeloid leukemia harboring the KTM2A-TET1 fusion gene. International Journal of Hematology. 2018. 108. 1
  • 若井 進, 柿島 裕樹, 山口 佳織, 角南 久仁子, 古田 耕, 吉田 朗彦, 松下 弘道. FISH検査後のスライド標本からの再染色(Reprobing)に関する検討. 臨床病理. 2017. 65. 補冊. 242-242
  • Matsushita Hiromichi, Kawai Hidetsugu, Tanaka Masayuki, Harada Hironori, Harada Yuka, Amaki Jun, Sheng Yin, Shiina Takashi, Onizuka Makoto, Ando Kiyoshi. 急性骨髄性白血病に対するターゲットシークエンスパネル(Targeted next-generation sequencing in acute myeloid leukemia). 臨床血液. 2017. 58. 9. 1514-1514
  • The infiltration of malignant lymphoma cells in the peripheral blood. 2017. 61. 8. 984-991
more...
Books (5):
  • 松下弘道、宮地勇人. 乳酸アシドーシス: がん救急マニュアル
    大江裕一郎、新海哲、高橋俊二 編、メジカルビュー社、東京 2011
  • M. Kizaki, H. Matsushita and Y. Ikeda. Therapeutic applications of ribozymes for leukemic cells with t(8;21) and the mechanism of their anti-leukemic effect. Bio Techniques Books: Ribozyme Biochemistry and Biotechnology
    (Ed) Krupp G, Eaton Publishing, Natick, MA 2000
  • M. Kizaki, H. Matsushita and Y. Ikeda. Therapeutic applications of ribozymes for leukemic cells with t(8;21) and the mechanism of their anti-leukemic effect. Bio Techniques Books: Ribozyme Biochemistry and Biotechnology
    (Ed) Krupp G, Eaton Publishing, Natick, MA 2000
  • Matsushita H, Kobayashi H, Mori S, Kizaki M, Ikeda Y: Ribozyme targeted against AML1/MTG8: Evaluation of ribozyme efficiency in a cell-free system and transfection with cationic liposome.
    Methods in Molecular Medicine, vol 11: Therapeutic applications of ribozymes(Ed) Scanlon KJ, Humana Press Inc., Totowa, NJ 1998
  • Matsushita H, Kobayashi H, Mori S, Kizaki M, Ikeda Y: Ribozyme targeted against AML1/MTG8: Evaluation of ribozyme efficiency in a cell-free system and transfection with cationic liposome.
    Methods in Molecular Medicine, vol 11: Therapeutic applications of ribozymes(Ed) Scanlon KJ, Humana Press Inc., Totowa, NJ 1998
Education (2):
  • - 1996 Keio University Graduate School of Medicine
  • - 1992 Keio University School of Medicine Depertment of Medicine
Professional career (1):
  • Doctor of Medical Science (Keio University (Japan))
Work history (8):
  • 2022/04 - 現在 Keio University
  • 2019/06 - 2022/03 National Cancer Center
  • 2019/04 - 2019/05 National Cancer Center
  • 2016/04 - 2019/03 National Cancer Center Hospital
  • 2012 - 2016/03 Tokai University School of Medicine
Show all
Association Membership(s) (9):
American Society of Hematology ,  日本癌学会 ,  日本内科学会 ,  日本臨床検査医学会 ,  日本血液学会 ,  日本臨床微生物学会 ,  日本臨床化学会 ,  日本医療検査科学会 ,  日本検査血液学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page